Brought to you by:
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S. The nonprofit investigative news outlet published three articles in its latest round of investigations looking into Medicare…
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across the medical field. The CMSS, a coalition of 53 specialty societies representing over 800,000 physicians, has…
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for ‘relatively benign’ disease trend upward
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the bold statement during the recent 2023 VEITHsymposium (Nov. 14–18) as he pointedly asked a room full…
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers for Medicare & Medicaid Services (CMS) coverage expansion; updated analyses from the VOYAGER PAD clinical trial;…
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD) were presented at the American Heart Association (AHA) 2023 Scientific Sessions (Nov. 11–13) in Philadelphia. The…
SVS Foundation step challenge helps place lens on ‘under-appreciation’ of country’s PAD problem
“We have a critical problem in America, which is the under-appreciation of peripheral arterial disease [PAD],” says Vikram Kashyap, MD, on his first time participating in the SVS Foundation’s Vascular Health Step Challenge, which concluded in September. Kashyap, a member…
Cyclical-pressure Topical Wound Oxygen therapy emerges as a proven wound-healing device for diabetic foot ulcers, showing great promise in venous leg ulcers
This advertorial is sponsored by AOTI. Enrico Ascher, MD, and Natalie Marks, MD, currently combine for close to 60 years of vascular surgery practice experience in New York City’s 3 million-strong populous borough of Brooklyn. Between them they see a…
DETOUR1 and DETOUR2 pooled analysis of bypass system reveals primary rate of 68.1% through 24 months
Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system. The Detour system offers a novel approach to treating complex peripheral arterial disease (PAD), enabling physicians to bypass…
Use of IVUS reduces patient risk of MALE or death by up to 28%: Data support consensus views on importance of advanced visualization for peripheral vascular disease interventions
This advertorial is sponsored by Philips. The benefits of utilizing intravascular ultrasound (IVUS) in peripheral vascular interventions has been widely demonstrated in the literature. In nearly every vascular bed studied, we have seen an improvement in overall outcomes. Over the…
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical. A press release details that, under the terms of the agreement, LimFlow will receive US$250 million in cash at closing and be eligible…